A Phase III Study to Evaluate the Immunogenicity and Safety of GC1107 (Adult Tetanus Diphtheria Vaccine) in Healthy Adults.

Published in: Journal of Korean medical science (2019)

ClinicalTrials.gov Identifier: NCT02361866.

Keyphrases